BIOLASE Total Assets 2011-2026 | BIOL

Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.

Main categories of assets
Current assets (used within one year):

Cash and cash equivalents
Accounts receivable (amounts owed by customers)
Inventory of goods, raw materials, and supplies
Short-term investments

Non-current assets (used for more than one year):

Fixed assets (buildings, machinery, equipment)
Intangible assets (brands, patents, software)
Long-term investments
Goodwill (reputational value from mergers)

Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.

Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.

Annual Total Assets BIOLASE

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
35.1 M	38.2 M	55.3 M	41 M	31.8 M	38.5 M	43 M	41.9 M	42.3 M	59.4 M	31 M	32 M	29.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
59.4 M	29.8 M	40 M

Quarterly Total Assets BIOLASE

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
27.2 M	30.6 M	34.4 M	35.1 M	38.7 M	39.6 M	41.9 M	38.2 M	42.9 M	50.9 M	50.2 M	55.3 M	58.5 M	61.2 M	63.5 M	41 M	41 M	41 M	41 M	31.8 M	31.8 M	31.8 M	31.8 M	38.5 M	38.5 M	38.5 M	38.5 M	43 M	43 M	43 M	43 M	41.9 M	41.9 M	41.9 M	41.9 M	42.3 M	42.3 M	42.3 M	42.3 M	59.4 M	59.4 M	59.4 M	59.4 M	31 M	31 M	31 M	31 M	32 M	32 M	32 M	32 M	29.8 M	29.8 M	29.8 M	29.8 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
63.5 M	27.2 M	40.6 M

Total Assets of other stocks in the Medical devices industry

Issuer	Total Assets	Price	% 24h	Market Cap	Country
Acutus Medical AFIB	54 M	-	-26.83 %	$ 2.62 M	USA
Allied Healthcare Products AHPI	19.7 M	-	3.58 %	$ 2.21 M	USA
GenMark Diagnostics, Inc. GNMK	224 M	-	-	$ 1.77 B	USA
Aziyo Biologics AZYO	43.4 M	-	1.37 %	$ 20.5 M	USA
Obalon Therapeutics, Inc. OBLN	10.6 M	-	-5.86 %	$ 30.6 M	USA
Bruker Corporation BRKR	5.81 B	$ 38.78	-1.25 %	$ 5.78 K	USA
Cognyte Software Ltd. CGNT	498 M	$ 8.15	4.22 %	$ 585 M	Israel
Conformis CFMS	94 M	-	-	$ 16.4 M	USA
AdaptHealth Corp. AHCO	4.32 B	$ 9.69	3.09 %	$ 1.31 B	USA
Apollo Endosurgery APEN	110 M	-	-	$ 475 M	USA
EDAP TMS S.A. EDAP	86.1 M	$ 4.15	4.01 %	$ 155 M	France
Cardiovascular Systems CSII	323 M	-	0.15 %	$ 844 M	USA
CONMED Corporation CNMD	2.33 B	$ 43.13	-0.43 %	$ 1.34 B	USA
Cutera CUTR	346 M	-	-10.19 %	$ 1.99 M	USA
CryoLife, Inc. CRY	789 M	-	-4.14 %	$ 702 M	USA
Avinger AVGR	13.8 M	-	-20.74 %	$ 369 K	USA
AxoGen AXGN	222 M	$ 29.17	-2.21 %	$ 1.34 B	USA
Apyx Medical Corporation APYX	79.2 M	$ 3.31	4.42 %	$ 115 M	USA
Axonics Modulation Technologies AXNX	659 M	-	-	$ 3.31 B	USA
Dynatronics Corporation DYNT	15.4 M	-	14.99 %	$ 929 K	USA
Eargo EAR	132 M	-	-	$ 10.2 M	USA
Electromed ELMD	53.8 M	$ 24.26	1.17 %	$ 205 M	USA
Soliton, Inc. SOLY	33.8 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	10.5 K	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	64.1 M	-	0.03 %	$ 1.58 B	Israel
Second Sight Medical Products EYES	41.6 M	-	-0.97 %	$ 54.4 M	USA
Accuray Incorporated ARAY	470 M	$ 0.53	0.68 %	$ 54.5 M	USA
Misonix, Inc. MSON	204 M	-	-	$ 462 M	USA
Neovasc NVCN	66.2 M	-	-	$ 111 M	Canada
FONAR Corporation FONR	199 M	$ 18.51	0.05 %	$ 121 M	USA
Cytosorbents Corporation CTSO	47.4 M	$ 0.79	-1.24 %	$ 43 M	USA
Align Technology ALGN	6.21 B	$ 183.14	0.27 %	$ 13.7 B	USA
Intersect ENT, Inc. XENT	227 M	-	-	$ 955 M	USA
Butterfly Network BFLY	256 M	$ 3.99	7.7 %	$ 845 M	USA
Abbott Laboratories ABT	86.7 B	$ 113.59	0.01 %	$ 198 B	USA
InMode Ltd. INMD	766 M	$ 13.58	-0.18 %	$ 878 M	Israel
BioSig Technologies BSGM	842 K	-	37.08 %	$ 85.7 M	USA
Boston Scientific Corporation BSX	43.7 B	$ 72.75	-1.49 %	$ 108 B	USA
IRadimed Corporation IRMD	98.3 M	$ 105.22	0.89 %	$ 1.33 B	USA
IRIDEX Corporation IRIX	34.4 M	$ 1.42	-0.7 %	$ 22.9 M	USA
Helius Medical Technologies HSDT	7.69 M	$ 2.31	16.67 %	$ 1.4 M	USA
Alphatec Holdings ATEC	791 M	$ 13.05	0.23 %	$ 1.96 B	USA
Pulmonx Corporation LUNG	163 M	$ 1.46	-4.58 %	$ 57.1 M	USA
Medigus Ltd. MDGS	37.5 M	-	10.28 %	$ 55.5 M	Israel
Medtronic PLC MDT	91.7 B	$ 95.96	-0.8 %	$ 123 B	USA
Edwards Lifesciences Corporation EW	13.7 B	$ 85.73	0.55 %	$ 50.1 B	USA
Inogen INGN	299 M	$ 6.33	1.93 %	$ 168 M	USA